Juan Harrison is Vice President, Strategic Partnerships and Business Development. He is responsible for developing institutional partnerships with industry to expand Harrington’s capabilities, resources and expertise to accelerate drug discovery and development.
Juan is a seasoned partnering professional with more than three decades of transaction and partnership building experience in the pharma, biotech and venture capital arenas. His experience covers licensing transactions, company formation, investment and partnership building, both on the buy and sell sides. He is particularly interested in the business translation of early-stage drug discovery to mature drug opportunities in organizations with the resources and capabilities to create bona fide medicines.
Prior to joining Harrington, Juan was CEO/CAO of IMIDomics Inc., an immunology-focused drug discovery company utilizing a deep, proprietary patient dataset and machine learning, where he led a multinational organization and presided over successful financings. Previously, he was VP Strategic Academic Alliances and VP Takeda Ventures at Takeda Pharmaceutical Company. He was responsible, together with the institutions, for establishing the Tri-Institutional Therapeutics Discovery Institute in New York, as well as the formation of Bridge Medicines, Inc., a translational company associated with the Tri-I TDI. While at Takeda Ventures, he spearheaded the financing of several biotech companies and the formation of Envoy Therapeutics, Inc. which was eventually acquired by Takeda. His work has been informed by an early career in pharmaceutical product development and his degree in Combined Sciences at Santa Clara University, which emphasized organic chemistry.